Abstract
We have investigated the pathological correlates of dementia in the brains from a consecutive series of 70 patients dying with a clinical diagnosis of frontotemporal lobar degeneration (FTLD). Clinical misdiagnosis rate was low with only 3 patients (4%) failing to show pathological changes consistent with this diagnosis; 1 patient had Alzheimer’s disease and 2 had cerebrovascular disease (CVD). In the remaining 67 patients, the most common underlying histological cause was ubiquitin pathology with 24 (36%) cases so affected. In these, ubiquitin-positive inclusions were present in the cerebral cortex as small, rounded or crescent-shaped structures within the cytoplasm of neurones of layer II, together with coiled or curvilinear bodies within neurites, and in the hippocampus as small, solid and more spherical-shaped inclusion bodies within the cytoplasm of dentate gyrus granule cells. In one patient, “cat’s eye” or “lentiform” intranuclear ubiquitin inclusions were also present. The second most common histological type was dementia lacking distinctive histology (DLDH), in which neither tau nor ubiquitin inclusions were present, with 16 cases (24%) being affected. Pick-type histology was seen in 14 cases (21%) and tau histological changes associated with frontotemporal dementia (FTD) linked to chromosome 17 (FTDP-17) were present in 11 cases (16%). One case (1%) showed an unusual tau pathology that could not be allocated to any of the other tau groups. Only 1 case (1%) had neuronal intermediate filament inclusion dementia. No cases with ubiquitinated, valosin-containing protein-immunoreactive intranuclear inclusion bodies of the type seen in inclusion body myopathy with Paget’s disease of bone and frontotemporal dementia were seen. Clinicopathological correlation showed that any of these histological subtypes can be associated with FTD. However, for FTD with motor neurone disease (FTD+MND), semantic dementia or primary progressive aphasia (PA), the histological profile was either ubiquitin type or DLDH type; Pick-type histology was seen in only 1 case of PA. None of these latter three clinical subtypes was associated with a mutation in tau gene and FTDP-17 type of tau pathology. All cases of progressive apraxia were associated with Pick-type histology. Present data therefore indicate that, although ubiquitin pathology is the most common histological form associated with FTLD, this pathology is not tightly linked with, nor is pathologically diagnostic for, any particular clinical form of the disease, including FTD+MND.
Similar content being viewed by others
References
Arai T, Nonaka T, Hasegawa M, Akiyama H, Yoshida M, Hashizume Y, Tsuchiya K, Oda T, Ikeda K (2003) Neuronal and glial inclusions in frontotemporal dementia with or without motor neuron disease are immunopositive for p62. Neurosci Lett 342:41–44
Babu JR, Geetha T, Wooten MW (2005) Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation. J Neurochem 94:192–203
Bergmann M, Kuchelmeister K, Schmid KW, Kretzschmar HA, Schroder R (1996) Different variants of frontotemporal dementia: a neuropathological and immunohistochemical study. Acta Neuropathol 92:170–179
Bigio EH, Lipton AM, White CL, Dickson DW, Hirano A (2003) Frontotemporal and motor neurone degeneration with neurofilament inclusion bodies: additional evidence for overlap between FTD and ALS. Neuropathol Appl Neurobiol 29:239–253
Bigio EH, Johnson NA, Rademaker AW, Fung BB, Mesulam MM, Siddique N, Dellfave L, Caliendo J, Freeman S, Siddique T (2004) Neuronal ubiquitinated intranuclear inclusions in familial and non-familial frontotemporal dementia of the motor neurone disease type associated with amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 63:801–811
Brooks B, Miller R, Swash M, Munsat T (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293–299
Brun A, Englund E, Gustafson L, Passant U, Mann DMA, Neary D, Snowden JS (1994) Clinical, neuropsychological and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 57:416–418
Cairns NJ, Perry RH, Jaros E, Burn D, McKeith IG, Lowe JS, Holton J, Rossor MN, Skullerud K, Duyckaerts C, Cruz-Sanchez FF, Lantos PL (2003) Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions. Neurosci Lett 341:177–180
Cairns NJ, Zhukareva V, Uryu K, Zhang B, Bigio E, Mackenzie IRA, Gearing M, Duyckaerts C, Yokoo H, Nakazato Y, Jaros E, Perry RH, Lee VM-Y, Trojanowski JQ (2004) α-Internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease. Am J Pathol 164:2153–2161
Forno LS, Langston WJ, Herrick MK, Wilson JD, Murayama S (2002) Ubiquitin-positive neuronal and tau 2-positive glial inclusions in frontotemporal dementia of motor neuron type. Acta Neuropathol 103:599–606
Froelich Fabre S, Axelman P, Almkvist A, Basun H, Lannfelt L (2003) Extended investigation of tau and mutation screening of other candidate genes on chromosome 17q21 in a Swedish FTDP-17 family. Am J Med Genet B Neuropsychiatr Genet 121B:112–118
Furukawa Y, Iseki E, Hino H, Odawara T, Ikeda K, Tsuchiya K, Kosaka K (2004) Ubiquitin and ubiquitin-related proteins in the brains of patients with atypical Pick’s disease without Pick bodies and dementia with motor neurone disease. Neuropathology 24:306–314
Hocking LJ, Lucas GJA, Daroszewska A, Mangion J, Olavesen M, Cundy T, Nicholson GC, Ward L, Bennett ST, Wuyts W, Van Hul W, Ralston SH. (2002) Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget’s disease. Hum Mol Genet 11:2735–2739
Hodges JR, Davies RR, Xuereb JH, Casey B, Broe M, Bak TH, Kril JJ, Halliday GM (2004) Clinicopathological correlates in frontotemporal dementia. Ann Neurol 56:399–406
Hosler B, Siddique T, Sapp PC, Sailor W, Huang MC, Hossain A, Daube JR, Nance M, Fan C, Kaplan J, Hung WY, McKenna-Yasek D, Haines JL, Pericak-Vance MA, Horvitz HR, Brown RH (2000) Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21–22. JAMA 284:1664–1669
Jackson M, Lennox G, Lowe J (1996) Motor neurone disease-inclusion dementia. Neurodegeneration 5:339–350
Josephs KA, Holton JL, Rossor MN, Braendgaard H, Osawa T, Fox NC, Petersen RC, Pearl GS, Ganguly M, Rosa P, Laursen H, Parisi JE, Waldemar G, Quinn NP, Dickson DW, Revesz T (2003) Neurofilament inclusion body disease: a new proteinopathy? Brain 126:2291–2303
Josephs KA, Holton JL, Rossor MN, Godbolt AK, Osawa T, Strand K, Knan N, Al-Sarraj S, Revesz T (2004) Frontotemporal lobar degeneration and ubiquitin immunohistochemistry. Neuropathol Appl Neurobiol 30:369–373
Kertesz A, Kawarai T, Rogaeva E, St George-Hyslop P, Poorkaj P, Bird TD, Munoz DG (2000) Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions. Neurology 54:818–827
Knopman D, Mastri AR, Frey WH, Sung JH, Rustan T (1990) Dementia lacking distinctive histologic features: a common non-Alzheimer degenerative dementia. Neurology 40:251–256
Kovari E, Leuba G, Savioz A, Saini K, Anastasiu R, Miklossy J, Bouras C (2000) Familial frontotemporal dementia with ubiquitin inclusion bodies and without motor neuron disease. Acta Neuropathol 100:421–426
Kovari E, Gold G, Giannakopoulos P, Bouras C (2004) Cortical ubiquitin-positive inclusions in frontotemporal dementia without motor neurone disease: a quantitative immunocytochemical study. Acta Neuropathol 108:207–212
Kuusisto E, Salminen A, Alafuzoff I (2001) Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies. Neuroreport 12:2085–2090
Kuusisto E, Salminen A, Alafuzoff I (2002) Early accumulation of p62 in neurofibrillary tangles in Alzheimer’s disease: possible role in tangle formation. Neuropathol Appl Neurobiol 28:228–237
Laurin N, Brown JP, Morissette J, Raymond V (2002) Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am J Hum Genet 70:1582–1588
Leigh PN, Anderton BH, Dodson A, Gallo JM, Swash M, Power DM (1988) Ubiquitin deposits in anterior horn cells in motor neuron disease. Neurosci Lett 93:197–203
Lipton AM, White CL III, Bigio EH (2004) Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration. Acta Neuropathol 108:379–385
Lowe JS, Lennox G, Jefferson D, Morrell K, McQuire D, gray T, Landon M, Doherty FJ, Mayer RJ (1988) A filamentous inclusion body within anaterior horn neurones in motor neurone disease defined by immunocytochemical localization of ubiquitin. Neurosci Lett 94:203–210
Mackenzie IRA, Feldman H (2003) The relationship between extramotor ubiquitin-immunoreactive neuronal inclusions and dementia in motor neurone disease. Acta Neuropathol 105:98–102
McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ; Workgroup on Frontotemporal dementia and Picks disease (2001) Clinical and pathological diagnosis of frontotemporal dementia: report of the workgroup on Frontotemporal dementia and Picks disease. Arch Neurol 59:1203–1204
Meyer A (1929) Über eine der amyotrophischen Lateralsklerose nahestende Erkrankung mit psychischen Störungen. Z Ges Neurol Psychiatr 121:107–128
Morita K, Kaiya H, Ikeda T, Namba M (1987) Presenile dementia combined with amyotrophy: a review of 34 Japanese cases. Arch Gerontol Geriatr 6:263–277
Mott RT, Dickson DW, Trojanowski JQ, Zhukareva V, Lee VM, Forman M, Van Deerlin V, Ervin JF, Wang DS, Schmechel DE, Hulette CM (2005) Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias. J Neuropathol Exp Neurol 64:420–428
Nakano T, Nakaso K, Nakashima K, Ohama E (2004) Expression of ubiquitin-binding protein p62 in ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis with dementia: analysis of 5 autopsy cases with broad clinicopathological spectrum. Acta Neuropathol 107:359–364
Neary D, Snowden JS, Mann DMA, Northen B, Goulding PJ, MacDermott N (1990) Frontal lobe dementia and motor neurone disease. J Neurol Neurosurg Psychiatry 53:23–32
Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51:1546–1554
Okamoto K, Murakami N, Kusaka H, Yoshida M, Hashizume Y, Nakazato Y, Matsubara E, Hirai S (1992) Ubiquitin-positive intraneuronal inclusions in the extramotor cortices of presenile dementia patients with motor neuron disease. J Neurol 239:426–430
Ostojic J, Axelman K, Lannfelt L, Froelich-Fabre S (2003) No evidence of linkage to chromosome 9q21–22 in a Swedish family with frontotemporal dementia and amyotrophic lateral sclerosis. Neurosci Lett 340:245–247
Pickering-Brown SM, Richardson AMT, Snowden JS, McDonagh AM, Burns A, Braude W, Baker M, Liu W-K, YenS-H, Hardy J, Hutton M, Davies Y, AllsopD, Craufurd D, Neary D, Mann DMA (2002) Inherited frontotemporal dementia in 9 British families associated with intronic mutations in the tau gene. Brain 125:732–751
Pickering-Brown S, Baker M, Bird T, Trojanowski J, Lee V, Morris H, Rosser M, Jannsen J, Neary D, Craufurd D, Snowden J, Richardson A, Hardy J, Mann D, Hutton M (2004) Evidence of a founder effect in families with frontotemporal dementia that harbour the tau +16 splice mutation. Am J Med Genet B Neuropsychiatr Genet 125B:79–82
Rademakers R, Cruts M, Dermaut B, Sleegers K, Rosso SM, Van Den Broeck M, Backhovens H, Swieten JC van, Duijn CM van, Broeckhoven C van (2002) Tau-negative frontal lobe dementia at 17q21: significant fine mapping of the candidate region to a 4.8-cm interval. Mol Psychiatry 7:1064–1074
Rosso SM, Kamphorst W, Graaf B de, Willemsen R, Ravid R, Niermeijer MF, Spillantini MG, Heutink P, Swieten JC van (2001) Familial frontotemporal dementia with ubiquitin positive inclusions is linked to chromosome 17q21–22. Brain 124:1948–1957
Rosso SM, Donker Kaat L, Baks T, Joosse M, Koning I de, Pijnenburg Y, Jong D de, Dooijes D, Kamphorst W, Ravid R, Niermeijer MF, Verheij F, Kremer HP, Scheltens P, Duijn CM van, Heutink P, Swieten JC van (2003) Frontotemporal dementia in the Netherlands: patient characteristics and prevalence estimates from a population based study. Brain 126:2016–2022
Rossor MN, Revesz T, Lantos PL, Warrington EK (2000) Semantic dementia with ubiquitin-positive tau-negative inclusion bodies. Brain 123:267–276
Sam M, Gutmann L, Schochet SS, Doshi H (1991) Pick’s disease: a case clinically resembling amyotrophic lateral sclerosis. Neurology 41:1831–1833
Savioz A, Kovari E, Anastasiu R, Rossier C, Saini K, Bouras C, Leuba G (2000) Search for a mutation in the tau gene in a Swiss family with frontotemporal dementia. Exp Neurol 161:330–335
Savioz A, Riederer BM, Heutink P, Rizzu P, Tolnay M, Kovari E, Probst A, Riederer IM, Bouras C, Leuba G (2003) Tau and neurofilaments in a family with frontotemporal dementia unlinked to chromosome 17q21–22. Neurobiol Dis 12:46–55
Schroder R, Watts GDJ, Mehta SG, Evert BO, Broich P, Fliessbach K, Pauls K, Hans VH, Kimonis V, Thal DR (2005) Mutant valosin-containing protein causes a novel type of frontotemporal dementia. Ann Neurol 57:457–461
Snowden JS, Neary D, Mann DMA (1996) Fronto-temporal lobar degeneration: fronto-temporal dementia, progressive aphasia, semantic dementia. Churchill Livingstone: Edinburgh, pp 1–227
Taniguchi S, McDonagh AM, Pickering-Brown SM, Umeda Y, Iwatsubo T, Hasegawa M, Mann DMA (2004) The neuropathology of frontotemporal lobar degeneration with respect to the cytological and biochemical characteristics of tau protein. Neuropathol Appl Neurobiol 30:1–18
Tolnay M, Probst A (1995) Frontal lobe degeneration: novel ubiquitin-immunoreactive neurites within frontotemporal cortex. Neuropathol Appl Neurobiol 21:492–497
Trojanowski JQ, Dickson D (2001) Update on the neuropathological diagnosis of frontotemporal dementias. J Neuropathol Exp Neurol 60:1123–1126
Vadlamudi RE, Joung K, Strominger JL, Shin J (1996) p62, a phosphotyrosine-independent ligand of SH2 domain of p56lck, belongs to a new class of ubiquitin-binding proteins. J Biol Chem 271:20235–20237
Watts GDJ, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, Pestronk A, Whyte MP, Kimonis VE (2004) Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 36:377–381
Wightman G, Anderson VER, Martin J, Swash M, Anderton BH, Neary D, Mann DMA, Luthert P, Leigh PN (1992) Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia. Neurosci Lett 139:269–274
Woulfe J, Kertesz A, Munoz D (2001) Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions. Acta Neuropathol 102:94–102
Zarrantz JJ, Ferrer I, Lezcano E, Forcadas MI, Eizaguirre B, Atares B, Puig B, Gomez-Esteban JC, Fernandez-Maiztegui C, Rouco I, Perez-Concha T, Fernandez M, Rodruigez O, Rodriguez-Martinez AB, Martinez de Pancorbo M, Pastor P, Perez-Tur J (2005) A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease. Neurology 64:1578–1585
Author information
Authors and Affiliations
Corresponding author
Additional information
The first two authors contributed equally
Rights and permissions
About this article
Cite this article
Shi, J., Shaw, C.L., Du Plessis, D. et al. Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation. Acta Neuropathol 110, 501–512 (2005). https://doi.org/10.1007/s00401-005-1079-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-005-1079-4